or
Bookmark and Share
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
   
Document Number
US Patent 6670366
Issued Date
December 30, 2003
Link
Map
Abstract
There is provided compounds of formula IA and of formula IB, ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and A have meanings given in the description, which are useful in the curative and prophylactic treatment of a medical condition for which inhibition of a cyclic guanosine 3',5'-monophosphate phosphodiesterase (e.g. cGMP PDE5) is desired.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
13
Comments:
no comments yet
Owner
Pfizer Inc (New York, NY)
Published
December 30, 2003
Application Number
09/426,552
Filed
October 22, 1999
US Classification
514/262.1   514/234.2 544/118 544/262 546/293 548/364.1 548/372.5
Int'l Classification
C07D   401/12   (20060101)   C07D   401/00   (20060101)   C07D   487/04   (20060101)   C07D   487/00   (20060101)   C07D   231/14   (20060101)   C07D   231/00   (20060101)  
Assistant Examiner
Priority Data
Oct 23, 1998 [GB] 9823101
USPTO Field of Search
540/575   546/247   546/193   546/293   514/218   514/234.2   514/262.1   544/118   544/256   544/262   548/364.1   548/372.5  
Related Patents
Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us